IL3RA and leukemia: We found that the mice treated with CTLA-4negative anti-CD123 CAR T cells demonstrated effective leukemia control whereas the mice treated with CTLA-4positive anti-CD123 CAR T cells had exponential tumor progression (Fig. 7f).